A Day Up For Assertio Therapeutics, Inc.
Fri, Feb 07, 2020 at 05:30 PM
Assertio Therapeutics, Inc. (ASRT:NASDAQ) jumped higher at $1.52, representing a gain of 46.2%. On Thu 06 Feb 20, ASRT:NASDAQ touched a New 2-Week Low of $1.04. The stock appeared on our News Catalysts scanner on Mon 13 Jan 20 at 10:28 AM in the 'RECOMMENDATION' category. From Thu 16 Jan 20, the stock recorded 28.57% Up Days and 40.00% Green Days
The stock spiked on Fri 27 Dec 19 at $1.69 with a volume of 9M+, and its share price has been moving sideways in recent weeks.
About Assertio Therapeutics, Inc. (ASRT:NASDAQ)
Depomed Inc is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system.
Top 10 Gainers:
- LightPath Technologies, Inc. (LPTH:NASDAQ), 51.28%
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 46.15%
- Benitec Biopharma Limited (BNTC:NASDAQ), 40.64%
- Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ), 32.23%
- Youdao, Inc. (DAO:NYSE), 29.12%
- Telenav, Inc. (TNAV:NASDAQ), 27.22%
- China Pharma Holdings, Inc. (CPHI:NYSEMKT), 26.94%
- Collegium Pharmaceutical, Inc. (COLL:NASDAQ), 25.37%
- Ocwen Financial Corporation (OCN:NYSE), 24.3%
- Synaptics Incorporated (SYNA:NASDAQ), 20.58%